Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.

Area of Science:

• Proteomics
• Animal Models
• Inflammatory Bowel Disease (IBD)

Background:

• Proteomics offers insights into protein roles in health and disease, particularly in IBD pathogenesis.
• Animal models of colitis provide a controlled environment to study IBD, complementing human studies.
• Previous research has identified potential biomarkers for disease activity.

Purpose of the Study:

• To review findings from proteomics studies in animal models of colitis.
• To understand protein roles and pathways in IBD at different disease stages.
• To explore therapeutic interventions and dietary components affecting intestinal inflammation.

Main Methods:

• Analysis of protein expression in animal models of colitis.
• Identification of proteins associated with inflammation, cellular structure, ER stress, and energy depletion.
• Monitoring protein expression changes to evaluate therapeutic effects.

Main Results:

• Proteomics studies elucidated protein importance across disease stages and identified activated/inhibited inflammatory pathways.
• Key proteins related to inflammation, cellular structure, endoplasmic reticulum stress, and energy depletion were identified.
• The roles of mesenteric lymphocytes, exosomes, and the intestinal mucosal barrier were highlighted.

Conclusions:

• Proteomics in animal models enhances understanding of intestinal cell responses to inflammation and repair.
• These studies reveal mechanisms of beneficial therapeutic interventions and food components.
• Future research directions include microbiota-IBD interactions and the gene-environmental axis of IBD.